It is, therefore, conceivable that CCL-4, CCL-5, CXCL-10 and IL-8 would initiate and maintain the inflammatory response in the acute phase of infection and the increased release of CCL-2 during the convalescent phase would regulate the immune response in order to reduce immune pathologies. This evidence concerns the gene CCL2 and infection.